Shop
Cart Details

Skyrizi® Risankizumab-Rzaa 150 Mg / Ml Injection Prefilled Syringe 1 Ml

  • Manufacturer Name : Janssen
  • MFG # : 74105001
  • NDC : 74105001
  • Distributor Name : McKesson - SAGEBRUSH
PID UOM Price Qty

You are not eligible to purchase this product. Please contact your account manager for more information.

Register For Member Price

 

Additional Information

Product NameSkyrizi® Risankizumab-Rzaa 150 Mg / Ml Injection Prefilled Syringe 1 Ml
ApplicationMonoclonal Antibody
Generic Drug NameRisankizumab-rzaa
Mechanism of ActionInhibits interleukin-23 (IL-23) by binding to the p19 subunit, reducing inflammation and abnormal skin cell turnover
Strength150 mg / mL
TypeSubcutaneous
Volume1 mL
Dosing ScheduleInitial dose, second dose at 4 weeks, then maintenance every 12 weeks
Common Side EffectsUpper respiratory infections, headache, fatigue, injection site reactions
Serious RisksIncreased risk of infections, allergic reactions, and liver dysfunction
Storage RequirementsRequires Refrigeration
Container TypePrefilled Syringe
UsesTreatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy

Description

Skyrizi® (risankizumab-rzaa) 150 mg/ml injection is a monoclonal antibody used for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It works by targeting and inhibiting interleukin-23 (IL-23), a key cytokine involved in the inflammatory process of psoriasis.

This medication is administered via a single-dose prefilled syringe, delivering a 150 mg dose of risankizumab-rzaa in a 1 mL solution. The recommended dosing schedule begins with an initial dose, followed by a second dose at 4 weeks, and subsequent maintenance doses every 12 weeks.

Common side effects of Skyrizi® include upper respiratory infections, headache, and fatigue. In rare instances, more serious side effects such as allergic reactions, infections, or liver dysfunction may occur. Patients should be monitored for signs of infection and should undergo screening for tuberculosis before starting treatment.

Frequently Asked Questions(FAQs)

The cost of Skyrizi® Risankizumab-Rzaa 150 Mg / Ml Injection Prefilled Syringe 1 Ml is available for registerd members only .
Skyrizi® Risankizumab-Rzaa 150 Mg / Ml Injection Prefilled Syringe 1 Ml is manufactured by Janssen.
Read More

Subscribe to Our Newsletter